Cambient Family Office LLC Makes New $4.01 Million Investment in Danaher Corporation $DHR

Cambient Family Office LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 17,495 shares of the conglomerate’s stock, valued at approximately $4,011,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. McLaughlin Asset Management Inc. purchased a new stake in shares of Danaher in the fourth quarter worth $495,000. Wick Capital Partners LLC purchased a new position in shares of Danaher during the 4th quarter valued at $761,000. Compound Planning Inc. boosted its holdings in Danaher by 47.1% in the 4th quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock worth $2,187,000 after buying an additional 3,060 shares during the period. Invesco Ltd. boosted its holdings in Danaher by 8.1% in the 4th quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock worth $943,201,000 after buying an additional 307,095 shares during the period. Finally, Evansbrook LLC purchased a new stake in Danaher in the 4th quarter worth $282,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 0.0%

Shares of DHR stock opened at $177.74 on Friday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock’s 50-day moving average price is $179.99 and its 200-day moving average price is $203.25. The stock has a market capitalization of $125.80 billion, a price-to-earnings ratio of 34.38, a price-to-earnings-growth ratio of 2.27 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 earnings per share. Equities research analysts predict that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. UBS Group lowered their price target on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Evercore upped their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Finally, Barclays cut their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.